Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5-HT7 receptors in Alzheimer's disease
Maite Solas, Debby Van Dam, Jana Janssens, et al.
Neurochemistry International (2021) Vol. 150, pp. 105185-105185
Open Access | Times Cited: 25

Showing 25 citing articles:

Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases
Yueqin Li, Yao Peng, Yingbin Shen, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 29, pp. 9816-9842
Closed Access | Times Cited: 103
The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer’s disease: A narrative review
Emma Aaldijk, Yannick Vermeiren
Ageing Research Reviews (2022) Vol. 75, pp. 101556-101556
Open Access | Times Cited: 92
Advances in Alzheimer’s disease’s pharmacological treatment
Carlos Elias Conti Filho, Lairane Bridi Loss, Clairton Marcolongo-Pereira, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 50
Pathophysiology of Alzheimer’s Disease
Brandon C. Yarns, Kelsey A. Holiday, David M. Carlson, et al.
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 4, pp. 663-676
Closed Access | Times Cited: 38
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Michael Colwell, Hosana Tagomori, Sarah Chapman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Amygdala neuronal dyshomeostasis via 5‐HT receptors mediates mood and cognitive defects in Alzheimer's disease
Xinrong Wu, Xiaona Zhu, Yuan‐Bo Pan, et al.
Aging Cell (2024) Vol. 23, Iss. 8
Open Access | Times Cited: 7
Hypoglycemic TCM formulas (Huangqi-Gegen drug pair) have the potential as an Alzheimer's disease
Yang Hai, Ke Ren, Wenqian Hou, et al.
Phytomedicine (2024) Vol. 130, pp. 155723-155723
Closed Access | Times Cited: 4
An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 4
Exploring Potential Medications for Alzheimer’s Disease with Psychosis by Integrating Drug Target Information into Deep Learning Models: A Data-Driven Approach
Oshin Miranda, Chen Jiang, Xiguang Qi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1617-1617
Open Access
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer’s Disease
Paola Gualtieri, Giulia Frank, Rossella Cianci, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 922-922
Open Access
Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms
Damian Kułaga, Anna K. Drabczyk, Przemysław Zaręba, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117995-117995
Closed Access
Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
Dmitrii V Eremin, Е. М. Кондаурова, Aleksander Ya Rodnyy, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 12-13, pp. 2023-2042
Closed Access | Times Cited: 10
Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction
Battistina Asproni, Marco Catto, Giovanni Loriga, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 84, pp. 117256-117256
Open Access | Times Cited: 6
The Importance of Stereochemistry in 5-HT7R Modulation─A Case Study of Hydantoin Derivatives
Katarzyna Kucwaj‐Brysz, Sebastian Baś, Ewa Żesławska, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3884-3900
Open Access | Times Cited: 1
Effects of the therapeutic correction of U1 snRNP complex on Alzheimer’s disease
Carles Leal, Camila G M Zimmer, Vanessa de V. C. Sinatti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord
Masaaki Yoshikawa, Chihiro Ishikawa, Haiyan Li, et al.
Molecular and Cellular Neuroscience (2022) Vol. 121, pp. 103745-103745
Open Access | Times Cited: 7
The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence
Yang Lu, Yanfei Cheng, Yicheng Zhu, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2387-2414
Closed Access | Times Cited: 2
Patterns of Expression of the Key Genes of the BDNF System and Serotonin Receptors in the Brain of OXYS Rats in the Development of the Signs of Alzheimer’s Disease
Mohammed Saad Alsallum, Ya. P. Kaminskaya, А. С. Цыбко, et al.
Advances in Gerontology (2023) Vol. 13, Iss. 2, pp. 84-93
Closed Access | Times Cited: 2
Comprehensive analysis of genetic risk loci uncovers novel candidate genes and pathways in the comorbidity between depression and Alzheimer’s disease
Bente Hofstra, Martien J. Kas, Dineke S. Verbeek
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
The association of T102C (rs6313) polymorphism in the 5-HT2A receptor gene with temporomandibular disorders and anxiety in a group of Turkish population
Ömer Ekici, Evrim Suna Arıkan Söylemez
CRANIO® (2024), pp. 1-9
Closed Access
Effect of amisulpride on the expression of serotonin receptors, neurotrophic factor BDNF and its receptors in mice with overexpression of the aggregation-prone [R406W] mutant tau protein
Е. М. Кондаурова, A. A. Komarova, Tatiana V. Ilchibaeva, et al.
Vavilov Journal of Genetics and Breeding (2024) Vol. 28, Iss. 4, pp. 398-406
Open Access
Development of a 5-HT7 receptor antibody for the rat: the good, the bad, and the ugly
Janice Thompson, Will Tragge, Emma D Flood, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 10, pp. 2599-2611
Open Access | Times Cited: 1
Serotonin receptors - a potential target for the treatment of Alzheimer’s disease
D. Eremin, Е. М. Кондаурова, A. Ya Rodny, et al.
Биохимия (2023) Vol. 88, Iss. 12, pp. 2399-2421
Closed Access | Times Cited: 1
Comprehensive analysis of genetic risk loci uncovers novel candidate genes and pathways in the comorbidity between depression and Alzheimer’s disease
Dineke S. Verbeek, Bente Hofstra, Martien J. Kas
Research Square (Research Square) (2023)
Open Access
Stress induced exacerbation of Alzheimer’s disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885
Hari Shanker Sharma, Lianyuan Feng, Dafin F. Mureşanu, et al.
International review of neurobiology (2023), pp. 3-46
Closed Access
Page 1

Scroll to top